순천향대학교 부속 부천병원은 경기도 부천시 중동에 있는 순천향대학교 산하의 종합병원이다.

During the past decade, Soonchunhyang University Bucheon Hospital conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 15 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Soonchunhyang University Bucheon Hospital" #1 sponsor was "Seung-Jung Park" with 27 trials, followed by "Soonchunhyang University Hospital" with 10 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Pfizer" with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Soonchunhyang University Bucheon Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 30 trials as a collaborator, "Severance Hospital" with 6 trials as a collaborator, "Pusan National University Hospital" with 4 trials as a collaborator, "Seoul National University Hospital" with 4 trials as a collaborator and "Soonchunhyang University Hospital" with 4 trials as a collaborator. Other collaborators include 106 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "Soonchunhyang University Bucheon Hospital" are "Coronary Artery Disease" (26 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Breast Cancer" (4 trials), "Multiple Myeloma" (4 trials) and "Dermatitis, Atopic" (3 trials). Many other conditions were trialed in "Soonchunhyang University Bucheon Hospital" in a lesser frequency.

Most popular intervention types in "Soonchunhyang University Bucheon Hospital" are "Drug" (77 trials), "Device" (28 trials), "Procedure" (14 trials), "Biological" (6 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Cypher" (4 trials), "Aspirin monotherapy" (2 trials), "Aspirin,Clopidogrel" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Soonchunhyang University Bucheon Hospital" are 133 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Soonchunhyang University Bucheon Hospital". undefined are not yet recruiting, 26 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Soonchunhyang University Bucheon Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Soonchunhyang University Bucheon Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 15 trials that are defined as “Not Applicable".

Soonchunhyang University Bucheon Hospital has several departments that took part in Clinical trials: "Digestive Disease Center, Soonchunhyang University Hospital" - 6 trials, "Soonchunhyang University College of Medicine" - 5 trials, "Soonchunhyang University Hospital, Buchen" - 4 trials, "Tae Hoon Lee" - 3 trials, "Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine" - 2 trials, "Department of Neuropsychiatry, Soonchunhyang University Hospital" - 2 trials